


| Key | % Net Assets |
|---|---|
| 5.1% | |
| 4.4% | |
| 4.3% | |
| 4.1% | |
| 82.1% |
| Name | % Net Assets |
|---|---|
| HSBC | 5.1% |
| British American Tobacco | 4.4% |
| Centrica | 4.3% |
| Royal Dutch Shell 'B' | 4.1% |
| BP | 3.5% |
| Vodafone | 3.5% |
| Aviva | 3.5% |
| GlaxoSmithKline | 3.5% |
| National Grid | 3.5% |
| AstraZeneca | 3.3% |
| Key | % Net Assets |
|---|---|
| 26.50% | |
| 18.70% | |
| 15.50% | |
| 9.50% | |
| 7.30% |
| Date | 24-May-2013 |
|---|---|
| NAV | 418.06p |
| Currency | GBP |
| Change | -8.30p |
| % | -1.95% |
| YTD change | 52.63p |
| YTD % | 14.40% |
| Fund Inception | 07/04/2006 |
|---|---|
| Fund Manager | Pan European Equities Team |
| TER | 1.12 (31-Jan-2012) |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research